AstraZeneca defends slow supplies to the EU, but says it ordered 3 months later than the UK

AstraZeneca has defended its delayed rollout of the coronavirus vaccine to the EU, saying the drugmaker is “working 24/7” to fix production issues.
The EU has reacted angrily to a delay in AstraZeneca’s supply of coronavirus vaccine, which is expected to be approved by the European medicines regulator by the end of the week, to the bloc.